DaVita Inc. (FRA:TRL)

Market Cap	6.50B -49.8%
Revenue (ttm)	11.35B +5.1%
Net Income	657.90M -6.7%
EPS	8.32 +5.6%
Shares Out	n/a
PE Ratio	9.88
Forward PE	8.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	18
Open	90.60
Previous Close	90.90
Day's Range	90.60 - 92.76
52-Week Range	86.70 - 172.05
Beta	n/a
RSI	46.91
Earnings Date	Feb 2, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Employees: 76,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TRL

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Financial numbers in USD